Exero Medical
Tel Aviv, Israel· Est.
Real‑time surgical‑drain sensor platform for early detection of GI anastomotic leaks.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $12.7M
AI Company Overview
Real‑time surgical‑drain sensor platform for early detection of GI anastomotic leaks.
Gastrointestinal surgerySurgical complications
Technology Platform
Electrode sensors embedded in a standard surgical drain continuously measure tissue impedance and motility to detect early anastomotic leaks and ischemia.
Opportunities
Early leak detection can significantly reduce morbidity, mortality, and hospital costs, opening pathways to adoption in high‑volume GI surgery centers and potential expansion to other surgical specialties.
Risk Factors
Regulatory approval timelines, reimbursement uncertainty, and competition from imaging‑based and biomarker detection methods could delay commercial launch.
Competitive Landscape
Competes with imaging, biomarker assays, and emerging wearable sensors; differentiation lies in real‑time electrophysiological data integrated into existing drain workflows.